Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-05

FDA Approved: BENZTROPINE MESYLATE — Original Application (Navinta LLC)

View source ↗

Summary

FDA approved Navinta LLC's original application for benztropine mesylate, a generic anticholinergic drug indicated for Parkinsonism and drug-induced extrapyrami…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benztropine Mesylate (benztropine mesylate)

Snippet

ORIG AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)